the microsampling blog / cannabis and cannabinoids

In some territories, which are listed in our website footer, our microsampling devices are supplied for therapeutic or IVD use as referenced in some of our content. Outside of those territories our devices are supplied for research use only (RUO).

research of CBD treatment in pediatrics using VAMS

by James Rudge, PhD, Technical Director, Neoteryx | 5 min read

research of CBD treatment in pediatrics using VAMS

An article published by Pasquale Striano et al at Giannina Gaslini Institute (IRCCS), Italy in the July 2020 issue of Molecules, reported on using Mitra® devices based on VAMS® to …

Read Story

VAMS to measure cannabinoids in pediatric studies

by James Rudge, PhD, Technical Director, Neoteryx | 4 min read

VAMS to measure cannabinoids in pediatric studies

An article published by Ganesh S. Moorthy et al at Children's Hospital of Philadelphia (CHOP) in the November 2019 issue of Journal of Chromatography B reported on a thorough validation …

Read Story
Prev All Posts Next
Content not found

Learn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!

search our blog

social media

subscribe to the blog

Fuel Your Innovative Approach to Science & Research. Subscribe to Our Microsampling Newsletter!

Get Our Newsletter

 

Get in Touch

 

Neoteryx, LLC

© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501

This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.

part-of-trajan-family-logo-white-text

 

Get To Know Us

Follow Us

Mitra® devices are intended as a specimen collector and for the storage and transport of blood. They are CE-IVD in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada and Ukraine. 

In the USA, Mitra devices are supplied as a Research-Use Only (RUO) product, to assist in method development, other research-related and non-diagnostic activities. Mitra has not been validated for use with any diagnostic testing. The suitability of Mitra for any analytical application must be evaluated and validated by the laboratory or research institute in a manner consistent with local regulatory requirements. 

hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. 

Mitra®, VAMS® & hemaPEN® are registered trademarks owned by Trajan Scientific Australia Pty Ltd. 

Copyright © 2022. All rights reserved.